Showing results (1551-1560 of 1,842) with videos related to
Sort By:
Pageof 185
Nature Methods|February 9, 2010
A nonviral minicircle vector for deriving human iPS cellsFangjun Jia, Kitchener D Wilson, Ning Sun, et al.Regulatory Toxicology and Pharmacology : RTP|July 11, 2020
Read-across: Principle, case study and its potential regulatory application in ChinaRenjun Gao, Na Guan, Mei Huang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2025
A BPTF-specific PROTAC degrader enhances NK cell-based cancer immunotherapyYunjia Li, Lin Bai, Hao Liang, et al.Journal of Clinical Gastroenterology|March 8, 2024
A Deep Learning Application of Capsule Endoscopic Gastric Structure Recognition Based on a Transformer ModelQingyuan Li, Weijie Xie, Yusi Wang, et al.Phytochemistry|February 19, 2024
Structurally diverse cucurbitane-type triterpenoids from the tubers of Hemsleya chinensis with cytotoxic activityXiao-San Li, Qi-Lin Wang, Zhi-Peng Xu, et al.Biochemical Pharmacology|April 12, 2011
UBE2M-mediated p27(Kip1) degradation in gemcitabine cytotoxicityA-Mei Huang, Yu-Ting Kao, Shinzao Toh, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2010
Autophagy negatively regulates keratinocyte inflammatory responses via scaffolding protein p62/SQSTM1Hye-Mi Lee, Dong-Min Shin, Jae-Min Yuk, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2010
CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cellsYen-Chun Pan, Chien-Feng Li, Chiung-Yuan Ko, et al.Oncotarget|November 19, 2016
miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PDTao Hu, Ye-Fei Chang, Zhangang Xiao, et al.CPT: Pharmacometrics & Systems Pharmacology|July 4, 2021
Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology ConsiderationsXinyuan Zhang, Yuching Yang, Manuela Grimstein, et al.Pageof 185